Clinical Trial Update: Colchicine Counteracting Inflammation in COVID-19 Pneumonia [Phase 2]

View source ↗

Summary

Phase 2 trial investigating colchicine to counteract inflammation in COVID-19 pneumonia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronavirus Infections
• Pneumonia Viral

Drugs mentioned

• COLCHICINE (Colchicine)

Snippet

Sponsor: Azienda Ospedaliero-Universitaria di Parma | Conditions: Coronavirus Infections, Pneumonia, Viral | Phase 2 | Status: COMPLETED